CROSS-SECTIONAL STUDY OF ASSOCIATION BETWEEN GLYCEMIC CONTROL AND QUALITY OF LIFE AMONG DIABETIC PATIENTS
Objective: The present study aimed to evaluate the association between glycemic control and quality of life (QoL) in people with type 2 diabetes
mellitus (T2DM) and identify that factors that influence glycemic control and QoL.
Methods: This cross-sectional study was conducted at the general hospital in Depok City from October to December 2017. Respondents were
outpatients diagnosed with T2DM, receiving routine care at the hospital. Glycemic control was assessed using glycated hemoglobin (HbA1c) levels,
while QoL was measured using an Indonesian version of the validated 5-level EuroQol 5-Dimensional.
Results: Among 108 participants, HbA1c levels were influenced by age, DM disease duration, DM treatment adherence, glycemic control, diet, and
physical activity suitable for patients with DM. The mean QoL value was 0.74Â±0.23 and the visual analog scale (VAS) score was 65.49Â±15.96. The QoL
values of patients with DM were influenced by HbA1c levels, duration of DM, and physical activity, while the VAS score was significantly affected by
HbA1c levels and duration of DM.
Conclusion: The present study showed that the QoL of T2DM patients was significantly influenced by glycemic control and other factors.
Health Organization; 2015. Available from: http://www.apps.who.int/
iris/bitstream/10665/204871/1/9789241565257_eng.pdf. [Last cited on
2017 Apr 28].
2. Larasati TA. Quality of life patient with diabetes melitus Type 2 in
Abdul Moeloek hospital province lampung. J Kedokteran Kesehatan
Univ Lampung 2012;2:17-20.
3. World Health Organization. Global Health Observatory (GHO)
Data: Mortality and Global Health Estimates. Geneva: World Health
Organization; 2015. Available from: http://who.int/gho/mortality_
burden_disease/en. [Last cited on 2017 Apr 28].
4. Ostgren C, Lindbland U, Ranstam J, Melander A, Rastam L. Glycemic
control, disease duration and Î²-cell function in patients with type 2
diabetes in a Swedish community. Diabetes Med 2002;19:125-9.
5. Wang P, Luo N, Tai ES, Thumboo J. The EQ-5D-5L is more
discriminative than the EQ-5D-3L in patients with diabetes in
Singapore. Value Health Reg Issues 2016;9:57-62.
6. American Diabetes Association. Standards of medical care in
diabetes-2017. Diabetes Care 2017;40 Suppl 1:S1-35.
7. Shah BM, Mezzio DJ, Ho J, Ip EJ. Association of ABC (HbA1c, blood
pressure, LDL-cholesterol) goal attainment with depression and healthrelated
quality of life among adults with Type 2 diabetes. J Diabetes
8. AminiLari Z, Fararouei M, Amanat S, Sinaei E, Dianatinasab S,
AminiLari M, et al. The effect of 12 weeks aerobic, resistance, and
combined exercises on omentin-1 levels and insulin resistance among
Type 2 diabetic middle-aged women. Diabetes Metab J 2017;41:205-12.
9. Aro AK, Karjalainen M, Tiihonen M, Kautiainen H, Saltevo J,
HaanpÃ¤Ã¤ M, et al. Glycemic control and health-related quality of life
among older home-dwelling primary care patients with diabetes. Prim
Care Diabetes 2017;11:577-82.
10. EuroQol Research Foundation. EQ-5D Instruments: About EQ-5D.
Rotterdam: EuroQol Research Foundation; 2017. Available from:
https://www.euroqol.org/deq-5d-instruments. [Last cited 2017 Apr 28].
11. Bourdel-Marchasson I, Druet C, Helmer C, Eschwege E, Lecomte P,
Le-Goff M, et al. Correlates of health-related quality of life in French
people with Type 2 diabetes. Diabetes Res Clin Pract 2013;101:226-35.
12. Sakamaki H, Ikeda S, Ikegami N, Uchigata Y, Iwamoto Y, Origasa H,
et al. Measurement of HRQL using EQ-5D in patients with Type 2
diabetes mellitus in Japan. Value Health 2006;9:47-53.
13. Triplitt CL, Reasner CA. Diabetes mellitus. In: Dipiro JT, Talbert RL,
Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy.
A Pathophysiologic Approach. 10th ed. New York: The McGraw-Hill
Medical; 2017. p. 3212-92.
14. Kuznetsov L, Griffin SJ, Davies MJ, Lauritzen T, Khunti K, Rutten GE,
et al. Diabetes-specific quality of life but not health status is
independently associated with glycaemic control among patients with
type 2 diabetes: A cross-sectional analysis of the ADDITION-Europe
trial cohort. Diabetes Res Clin Pract 2014;104:281-7.
15. Purba FD, Hunfeld JA, Iskandarsyah A, Fitriana TS, Sadarjoen
SS, Ramos-GoÃ±i JM, et al. The Indonesian EQ-5D-5L value set.
16. Endarti D, Riewpaiboon A, Thavorncharoensap M, Praditsitthikorn N,
Hutubessy R, Kristina SA, et al. A comparison of EQ-5D-3L index scores
using Malaysian, Singaporean, Thai, and UK value sets in Indonesian
cervical cancer patients. Value Health Reg Issues 2018;15:50-5.
17. Lemeshow S, Hosmer DW, Klar J, Lwanga SK. Adequacy of Sample
Size in Health Studies. England: World Health Organization; 1990.
18. Rwegerera G, Moshomo T, Gaenamong M, et al. Health-related quality
of life and associated factors among patients with diabetes mellitus in
Botswana. AJM 2017;54:111-8.
19. Vidal-Peracho C, Lucha-LÃ³pez MO, Lucha-LÃ³pez AC,
TricÃ¡s-Moreno JM, EstÃ©banez-De Miguel E, BernuÃ©s-VÃ¡zquez L, et al.
A descriptive study of health status and health related quality of life in
selected outpatients with type 2 diabetes, pathological body mass index
and cardiovascular risk in Spain. Diabetol Metab Syndr 2014;6:135.
20. Parsa P, Ahmadinia-Tabesh R, Mohammadi Y, Khorami N. Investigating the
relationship between quality of life with lipid and glucose levels in Iranian
diabetic patients. Diabetes Metab Syndr 2017;11 Suppl 2:S879-S883.
21. Ma Q, Liu H, Xiang G, Shan W, Xing W. Association between glycated
hemoglobin A1c levels with age and gender in Chinese adult with no
prior diagnosis of diabetes mellitus. Biomed Rep 2016;4:737-40.
22. Babazadeh T, Dianatinasab M, Daemi A, Nikbakht HA, Moradi F,
Ghaffari-Fam S, et al. Association of self-care behaviors and quality
of life among patients with Type 2 diabetes mellitus: Chaldoran county,
Iran. Diabetes Metab J 2017;41:449-56.
23. Heintz E, WirÃ©hn AB, Peebo BB, Rosenqvist U, Levin LÃ…. QALY
weights for diabetic retinopathy â€“ a comparison of health state
valuations with HUI-3, EQ-5D, EQ-VAS, and TTO. Value Health